(Q43995344)

28 November 2017

Adult cystic fibrosis exacerbations and new strains of Pseudomonas aeruginosa (English)

1 reference

28 November 2017

Pseudomonas aeruginosa

0 references

cystic fibrosis

0 references

author name string

Shawn D Aaron

1

1 reference

28 November 2017

Karam Ramotar

2

1 reference

28 November 2017

Wendy Ferris

3

1 reference

28 November 2017

Katherine Vandemheen

4

1 reference

28 November 2017

Raphael Saginur

5

1 reference

28 November 2017

Elizabeth Tullis

6

1 reference

28 November 2017

David Haase

7

1 reference

28 November 2017

Dan Kottachchi

8

1 reference

28 November 2017

Melissa St Denis

9

1 reference

28 November 2017

Francis Chan

10

1 reference

28 November 2017

language of work or name

English

0 references

publication date

11 December 2003

1 reference

American Journal of Respiratory and Critical Care Medicine

28 November 2017

1 reference

28 November 2017

169

1 reference

28 November 2017

7

1 reference

28 November 2017

811-815

1 reference

Determinants of mortality from cystic fibrosis in Canada, 1970-1989.

28 November 2017

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1306OC

Gender gap in cystic fibrosis mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1306OC

Defining a pulmonary exacerbation in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1306OC

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1306OC

Rational parameters for antibiotic therapy in patients with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1306OC

Multiple Isolates of Pseudomonas aeruginosa with Differing Antimicrobial Susceptibility Patterns from Patients with Cystic Fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1306OC

Significant microbiological effect of inhaled tobramycin in young children with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1306OC

Antibiotic treatment of initial colonization with Pseudomonas aeruginosa postpones chronic infection and prevents deterioration of pulmonary function in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1306OC

Effect of inhaled tobramycin on early Pseudomonas aeruginosa colonisation in patients with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1306OC

Quorum-sensing signals indicate that cystic fibrosis lungs are infected with bacterial biofilms

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1306OC

Single and combination antibiotic susceptibilities of planktonic, adherent, and biofilm-grown Pseudomonas aeruginosa isolates cultured from sputa of adults with cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1306OC

New antimicrobials in the management of cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1306OC

Pulsed-field gel electrophoresis analysis of a Pseudomonas aeruginosa pathovar

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1306OC

Heterogeneity of Pseudomonas aeruginosa in Brazilian cystic fibrosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1306OC

Reduction of sputum Pseudomonas aeruginosa density by antibiotics improves lung function in cystic fibrosis more than do bronchodilators and chest physiotherapy alone

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1306OC

Comparison of a beta-lactam alone versus beta-lactam and an aminoglycoside for pulmonary exacerbation in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1306OC

New strains of bacteria and exacerbations of chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1306OC

Direct sputum analysis of Pseudomonas aeruginosa macrorestriction fragment genotypes in patients with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1306OC

Longitudinal assessment of Pseudomonas aeruginosa in young children with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1306OC

Molecular epidemiology of chronic pulmonary colonisation by Pseudomonas aeruginosa in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200309-1306OC

10.1164/RCCM.200309-1306OC

21 January 2018

Identifiers

DOI

1 reference

28 November 2017

1 reference